# Reducing High Risk Primary Tumor Clinical Target Volumes (CTVp1) in Non-metastatic Nasopharyngeal Carcinoma

> **NCT05994170** · NA · RECRUITING · sponsor: **Zhongshan People's Hospital, Guangdong, China** · enrollment: 454 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma
- Intensity-Modulated Radiotherapy

## Interventions

- **RADIATION:** Reduction CTVp1
- **RADIATION:** Non-reduction CTVp1

## Key facts

- **NCT ID:** NCT05994170
- **Lead sponsor:** Zhongshan People's Hospital, Guangdong, China
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-04
- **Primary completion:** 2026-08-04
- **Final completion:** 2029-09-01
- **Target enrollment:** 454 (ESTIMATED)
- **Last updated:** 2023-08-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05994170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05994170, "Reducing High Risk Primary Tumor Clinical Target Volumes (CTVp1) in Non-metastatic Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05994170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*